A detailed history of Renasant Bank transactions in Johnson & Johnson stock. As of the latest transaction made, Renasant Bank holds 3,537 shares of JNJ stock, worth $570,058. This represents 0.38% of its overall portfolio holdings.

Number of Shares
3,537
Previous 2,711 30.47%
Holding current value
$570,058
Previous $428,000 20.56%
% of portfolio
0.38%
Previous 0.31%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$144.38 - $157.78 $119,257 - $130,326
826 Added 30.47%
3,537 $516,000
Q1 2024

May 09, 2024

SELL
$155.22 - $162.74 $7,295 - $7,648
-47 Reduced 1.7%
2,711 $428,000
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $6,697 - $7,308
-46 Reduced 1.64%
2,758 $432,000
Q3 2023

Nov 01, 2023

SELL
$155.75 - $174.48 $209,795 - $235,024
-1,347 Reduced 32.45%
2,804 $436,000
Q2 2023

Aug 01, 2023

BUY
$154.35 - $166.11 $53,713 - $57,806
348 Added 9.15%
4,151 $687,000
Q1 2023

May 05, 2023

BUY
$151.05 - $180.26 $58,909 - $70,301
390 Added 11.43%
3,803 $589,000
Q4 2022

Feb 09, 2023

SELL
$160.2 - $179.79 $40,210 - $45,127
-251 Reduced 6.85%
3,413 $602,000
Q3 2022

Nov 03, 2022

BUY
$161.33 - $179.52 $3,871 - $4,308
24 Added 0.66%
3,664 $599,000
Q2 2022

Aug 03, 2022

SELL
$168.19 - $186.01 $66,266 - $73,287
-394 Reduced 9.77%
3,640 $647,000
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $125,879 - $142,953
796 Added 24.58%
4,034 $715,000
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $340,707 - $378,026
-2,185 Reduced 40.29%
3,238 $554,000
Q3 2021

Oct 12, 2021

SELL
$161.5 - $179.47 $216,894 - $241,028
-1,343 Reduced 19.85%
5,423 $876,000
Q2 2021

Jul 19, 2021

BUY
$159.48 - $171.07 $108,286 - $116,156
679 Added 11.15%
6,766 $1.11 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $176,642 - $196,733
-1,154 Reduced 15.94%
6,087 $1 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $992,813 - $1.14 Million
7,241 New
7,241 $1.14 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $421B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Renasant Bank Portfolio

Follow Renasant Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

News

Stay updated on Renasant Bank with notifications on news.